| Jun 3 |
Illumina board approves spinoff of GRAIL
|
| Jun 3 |
Illumina's board approves to spin off Grail in June
|
| Jun 3 |
Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares
|
| Jun 3 |
Illumina appoints Everett Cunningham Chief Commercial Officer
|
| May 29 |
Illumina, Inc. (ILMN) Bernstein Strategic Decisions Conference (Transcript)
|
| May 29 |
Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO
|
| May 29 |
7 Large-Cap Stocks That Can Jump 50% By 2025
|
| May 28 |
Illumina releases 2023 Corporate Social Responsibility Report
|
| May 25 |
One Illumina Insider Raised Their Stake In The Previous Year
|
| May 24 |
Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok
|
